FIELD: medicine.
SUBSTANCE: method involves introducing water-soluble chemopreparation as a course in lymphotropic way. Riva-Rocci apparatus cuff is applied to lower part of femur and pressure of 40 mm of mercury column is created. 20 ml of chymotrypsin dissolved in 0.5% Novocain solution is subcutaneously introduced into the middle area of lateral shank surface 30 min later. Water-soluble chemopreparations are slowly subcutaneously introduced 0.5 cm below the chymotrypsin injection place in 5-7 min as single dose. The cuff is left in swollen state for 2 h. After having taken off the cuff, 50 ml of 0.5% Novocain solution is subcutaneously introduced into the place of previous water-soluble chemopreparations injection. Then the lower extremity is dressed with elastic bandage. The lymphotropic water-soluble chemopreparations introduction procedure is carried out once a day combined with standard chemotherapy course. Detralex is daily given to the patient on the background of the chemotherapy course at a dose of 2 pills twice a day combined with subcutaneous Fraxiparin injections introduced at a dose of 0.3 ml once a day.
EFFECT: avoided surgical intervention; increased antitumor effectiveness; reduced risk of recurrences, metastases and toxic complications.
5 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF LOCAL PROLONGED CHEMICAL-THERAPEUTIC TREATMENT OF LOCALLY SPREAD UNRESECTABLE GLANDULAR CANCER OF PELVIS MINOR ORGANS | 2010 |
|
RU2437660C1 |
METHOD OF PERSONALIZED NEOADJUVANT INTRA-ARTERIAL CHEMOTHERAPY OF GASTRIC CANCER | 2021 |
|
RU2797397C2 |
METHOD OF ADJUVANT THERAPY OF LOCALLY ADVANCED STOMACH CANCER | 2011 |
|
RU2465843C1 |
INTEGRATED THERAPY OF STOMACH CANCER | 2008 |
|
RU2375061C1 |
MIXED DOSAGE FORM OF CMF (CYCLOPHOSPHAN-METHOTREXATE-5-FLUOROURACIL), METHOD FOR PREPARING MIXED DOSAGE FORM OF CMF (CYCLOPHOSPHAN-METHOTREXATE-5-FLUOROURACIL) (VERSIONS) AND METHOD FOR LYMPHOTROPIC INTERSTITIAL ADMINISTRATION OF MIXED DOSAGE FORM OF CMF (CYCLOPHOSPHAN-METHOTREXATE-5-FLUOROURACIL) FOR TREATING TUMOURS | 2012 |
|
RU2500405C1 |
METHOD FOR TREATING CANCER | 2004 |
|
RU2271223C2 |
METHOD OF TREATING OPERABLE GASTRIC ADENOCARCINOMA | 2019 |
|
RU2706346C1 |
METHOD FOR TREATING CANCER CASES | 2005 |
|
RU2314105C2 |
METHOD FOR TREATING CANCER | 2005 |
|
RU2290934C1 |
METHOD FOR CANCER TREATMENT | 2003 |
|
RU2255738C2 |
Authors
Dates
2006-12-27—Published
2005-03-28—Filed